Thank you, Nina, and good morning, everyone. The third quarter was very strong across all our financial metrics. Net sales increased by 69% to 597 million, compared with 354 million in the same quarter last year. Adjusted EBITA increased by 93% to 83 million. And this means that earnings grew faster than sales. The adjusted EBITA margin consequently improved from 12.1% to 13.9% in the quarter, which we are very proud of. Operating cash flow amounted to 70 million in the quarter, corresponding to a cash conversion of 86%. Our financial position continues to be very strong. We are in a net cash position also in the third quarter, although we have conducted two acquisitions that were paid in cash in this quarter. Overall, the quarter combines high growth, margin expansion, strong cash flow, and a very solid balance sheet.
To illustrate the current earnings capacity of the group and our performance in more of a historical perspective, these slides show the development on an acquisition-adjusted basis. That means we are taking the full-year effect of the acquisitions we have made so far during the 12-month period. So reported net sales for the last 12-month period was 2.3 billion, which is up from 1.6 billion by the end of 2025. And if you include the businesses we have acquired during the last 12-month period, we had total sales of 2.6 billion. And the corresponding adjusted EBITA was 396 million, implying a margin of 15%.
So to summarize, our strong growth trend continues. And we also see that the acquisitions we have made so far this year will continue to contribute to the growth in the coming quarters as well. Looking at the growth bridge for this quarter, sales increased from 354 million to 597 million. Of that growth, acquisitions added 166 million or 47%. And the organic growth was 70 million or 20%. While the currency impact was 7 million or 2%. On the earnings side, adjusted EBITDA increased from 43 to 83 million, where the acquired growth amounted to 33 million and the organic growth contributed 8 million, or 18%. While the currency effect was neutral, the adjusted organic EBITDA growth was 18% compared with the organic sales growth of 20% in the third quarter; we saw organic growth in basically all business areas coming from very strong demand in several of our companies' markets. And if you compare to Q2, we had one company, Göfast, that had a particular impact on organic growth in Q3. The growth was actually spread over all business areas, which also explained why we now have a higher EBITA growth. Also to mention, the EBITDA figure was adjusted for 2 million in IPO-related expenses in this quarter. And for the first nine months, net sales increased by 61% from 1.1 billion to 1.8 billion. Of that, acquisitions contributed 591 million, or 44%, while organic growth was 195 million, or 17%, with limited currency effects, and adjusted EBITDA increased to 254 million, of which 110 million came from acquired growth and 27 million from organic growth. That corresponds to an adjusted organic EBITDA growth of 23%. So as we are now nine months into 2026, we can conclude that we have had a very strong year with solid growth in both sales and margins. So in total for 2026, EBITA has been adjusted for 19 million in IPO-related expenses and also 34 million gained from the sale of a minority interest in Svensk Fordonsladdning in the first quarter. Looking at the financial performance in a longer-term perspective, we have established a new level since the first quarter of this year, although individual quarters can be affected by seasonality, business mix, and project deliveries. I believe the trend is very clear, and the adjusted EBITDA margin has increased from 8.7% in the third quarter of 2023 to 13.9% in this quarter. And compared to a very strong second quarter 2026. EBITA now in Q3 was slightly lower at 83 million compared to 88 million. But considering that July is the holiday period in the Nordics, I believe Q3 was very strong also in that perspective. Looking at cash flow and cash conversion, we had a strong cash flow both in the quarter and also for the first nine months of this year. Operating cash flow amounted to 70 million. And that is after working capital changes and capital expenditures, corresponding to a cash conversion of 86% in relation to EBITDA. For the first nine months, operating cash flow was 244 million and the cash conversion was 91%. In this quarter, working capital had a negative effect of 15 million, which is mainly linked to the strong sales we had, in particular within the Regulatory Expertise business area. CapEx was very limited, with 3 million in the quarter and 8 million year to date, which actually confirms that we have an asset-light business model. During the first nine months, we completed a total of five acquisitions, for which we paid a consideration of 253 million. The operating cash flow generated during this period was equivalent to 96% of that amount. And as Nina mentioned before, this really illustrates the strength in our model, that we have a business that generates cash, and that cash can be reinvested to generate further profitable growth. So looking into our balance sheet, it is very strong. At the end of the quarter, we reported net debt of 80 million. And that includes lease liabilities, earn-outs, and also put/call options. And liabilities related to those are included. So if we exclude the lease liabilities related to premises, our financial net debt was -26 million. And this means that the group had a net cash position based on the definition that we use in our leverage target, and return on capital employed was 19%, compared with 15.9% at the same period last year. And this is above our medium-term target of 18% and really reflects the strong underlying performance with improving EBITA and growing cash flows that we've seen in this quarter and also throughout the last nine months. So with that, I will hand over to Nina to guide you through our recent acquisitions.